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Abstract 
Immune stimulating complex (iscom) matrix is a formulation that is used as an 
adjuvant within research. The capability of the iscom matrix to elicit an immune 
response when not present together with an antigen has not been extensively 
investigated. One way to evaluate the status of the immune system is to measure the 
amount of cytokines that usually are produced by various cell types during an immune 
response. The aim of the present study was to evaluate the early immune responses in 
porcine peripheral blood mononuclear cells (PBMC) after stimulation in vitro with the 
iscom matrix, AbISCO®-100. The immune response was evaluated by measuring the 
mRNA expression for various cytokines, a chemokine receptor (CXCR4) and 
regulator of G-protein signaling (RGS16) in porcine PBMC after stimulation with 
AbISCO®-100 or other inducers like a lipopolysaccharide (LPS) and a CpG 
oligodeoxynucleotide (ODN 2216) used as controls. Quantitative real-time PCR 
analysis showed low increase (p ≤ 0.05) in mRNA expression of the pro-inflammatory 
cytokine TNF-α after 6 hours of stimulation with AbISCO®-100. This result 
indicates that AbISCO®-100 may have the capacity to evoke a cytokine response by 
itself. In addition, low but detectable increases in expression of IL-10, CXCR4 and 
RGS16 were observed in one of five pigs after stimulation with AbISCO®-100. In 
comparison, mRNA for IL-1β, IL-6, IL-10 (p ≤ 0.001), IL-12p40 and TNF-α (p ≤ 
0.01) was induced after 6 hours exposure of the PBMC to LPS and for IFN-α (p ≤ 
0.01) after 6 h in the presence of ODN 2216. Proliferation and viability test 
performed, demonstrated that AbISCO®-100 was not mitogenic and just had a small 
lytic effect on the PBMC . Thus, the iscom matrix, AbISCO®-100, does not appear to 
be toxic or induce any harmful early inflammatory responses in porcine PBMC. An 
extended period of incubation and use of a lager number of pigs are needed to better 
examine the effects of AbISCO®-100. 
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Sammanfattning 
Immun-stimulerande komplex (iscom) matrix är en formulering, vilken i 
forskningssammanhang används, som adjuvant. Stimulering av immunaktivering i 
porcina PBMC med enbart iscom matrix (utan närvaro av ett antigen) är sparsamt 
redovisat i litteraturen. Ett sätt att utvärdera den immunreglerande effekten är att mäta 
mängden cytokiner som normalt produceras av olika celltyper under ett immunsvar. 
Syftet med denna studie var att utvärdera den tidiga immunaktiveringen i porcina 
PBMC efter stimulering in vitro med iscom matrix, AbISCO®-100. 
Immunaktiveringen utvärderades genom mätning av mRNA-uttryck för olika 
cytokiner, en kemokin receptor (CXCR4) och en regulator av G-protein signalering 
(RGS16) i porcina PBMC efter stimulering med iscom matrix AbISCO®-100 eller 
andra inducerare, som en lipopolysaccharid (LPS) och en CpG oligodeoxynukleotid 
(ODN 2216), vilka användes som kontroller. Kvantitativa real-tids PCR-analyser 
visade en liten höjning i mRNA uttryck (p ≤ 0.05) av det proinflammatoriska 
cytokinet TNF-α efter 6 timmars stimulering med AbISCO®-100. Det resultatet 
indikerar att AbISCO®-100 kan ha förmåga att väcka ett cytokinsvar. Låga 
detekterbara ökningar i uttryck av IL-10, CXCR4 och RGS16 kunde observeras i en 
av fem grisar efter stimulering med AbISCO®-100. I jämförelse hade mRNA för IL-
1β, IL-6, IL-10 (p ≤ 0.001), IL-12p40 och TNF-α (p ≤ 0.01) inducerats efter 6 
timmars exponering med LPS och för IFN-α (p ≤ 0.01) efter 6 timmars induktion med 
ODN 2216. Proliferations- och viabilitetstester, visade att AbISCO®-100 ej var 
mitogent och bara hade en liten lytisk effekt på PBMC. Följaktligen verkar inte iscom 
matrix, AbISCO®-100, vara toxisk eller inducera några skadliga tidiga 
inflammatoriska reaktionen i porcina PBMC. En längre inkubationstid och 
användning av ett större antal grisar behövs för att bättre kunna undersöka effekterna 
av AbISCO®-100. 
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Introduction 
 
An adjuvant is a substance that has the capacity to enhance the immune response 
when it is presented together with an antigen. AbISCO®-100 is an adjuvant 
formulation that corresponds to the structural components (the matrix) of immune 
stimulating complexes (iscoms). Iscoms formed by incorporation of defined antigen in 
their matrix have a well-documented capacity to induce protective immunity to a vast 
number of pathogens in several species.  
 
The iscom was first described 25 years ago by Morein et al. (1984) as a new 
particulate structure for antigen presentation. After that the iscom was tested in 
different animal models with the intention to develop safe and effective vaccines. The 
iscoms showed to be efficient inducers of both humoral and cellular immune 
responses with minimal side effects (Pearse & Drane, 2005). However the traditional 
iscom-based vaccines were limited to only presenting antigen consisting of 
hydrophobic parts of viral membrane proteins. Furthermore the antigen needed to be 
prepared together with the iscom structure and could not spontaneously be 
incorporated afterwards. New findings that enabled incorporation of a broader range 
of antigens have increased the usefulness of iscoms. To overcome difficulties in the 
manufacturing processes, the possibility to mix antigens with preformed iscom 
matrixes has been evaluated for use as vaccines (Sanders et al., 2005). 
 
The traditional iscom matrix consists of three components; cholesterol, saponin and 
phopholipid that form a 40 nm in diameter cage-like structure. Thus, the iscom matrix 
has the same composition and shape as the iscom but has no antigen incorporated 
(Sanders et al., 2005). The cholesterol functions as a ligand that binds to the saponin 
to form 12 nm rings, where the phospholipid glues the rings together, forming the 
cage-like structure (Morein et al., 2004). Both the cholesterol and the phospholipids 
can be produced synthetically, whereas the saponins are derived from the Quillaja 
saponaria Molina tree bark (Sanders et al., 2005). Free saponins are by themselves 
potent inducer of immune responses but may have negative side effects e.g. lytic 
properties. An advantage of using an iscom matrix as adjuvant (instead of free 
saponins) is that the haemolytic activity of the saponins in an iscom matrix is very 
much reduced (Morein et al., 2004). 
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AbISCO®-100 is a commercially available iscom matrix formulation aimed to be 
used in research. AbISCO®-100 consists of cholesterol, phospholipid and a combined 
structure of two saponin fractions, fraction A and fraction C. The cholesterol is 
produced from lanolin (from wool) and the phospholipid is a phosphatidyl choline 
obtained from fresh egg yolk. It has been tested in several animal species including 
mice, pigs, monkeys, non-human primates and horses but is particularly designed for 
use in mice (www.isconova.se). In the present study effects of AbISCO®-100 on 
porcine pheripheral blood mononuclear cells were tested in vitro. 
 
In the experiments the levels of mRNA expression of various cytokines, a chemokine 
receptor (CXCR4) and a regulator of G-protein signaling (RGS16) was measured after 
treatment with AbISCO®-100. Two additional stimulators, lipopolysaccharide (LPS) 
and a CpG oligodeoxynucleotide (ODN 2216) were included as positive controls for 
certain cytokines. The LPS forms part of gram-negative bacterial cell walls and has 
the capability to elicit an inflammatory response. ODN 2216 is synthetically made and 
contains “CpG”-motifs that mimic immunostimulatory DNA released by intracellular 
microbes.  
 
The mRNA expression was determined by quantitative real-time PCR analyze of the 
cytokines: IFN-α, IFN-γ, IL-6, IL-10, IL-12p40, IL-1β, TNF-α and TGF-β. Pro-
inflammatory cytokines like IL-1, IL-12 and TNF-α are elicited in the early stage of 
an immune response. The release of these cytokines facilitates production of the same 
cytokines or various others. For example, IL-12 activates cells to release IFN-γ 
whereas TNF-α stimulates the secretion of IL-6. There is a large number of cytokines 
that activate different cells of the immune system. However there are also inhibitory 
cytokines to counter balance these effects to keep the homeostatic level, for example, 
when a response is no longer needed. Two examples of cytokines with anti-
inflammatory properties are IL-10 and TGF-β. Thus, cytokines are the principal 
mediators of communication between cells in the immune system and consequently 
the ability of an adjuvant to induce cytokine production is important for its mode of 
immune regulation. 
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Materials and methods 
 
Inducers used for cytokine gene expression 
The inducers used were AbISCO®-100 (Isconova AB, Uppsala, Sweden), LPS 
(Sigma Aldrich, Steinheim, Germany) and ODN 2216 (Cybergene AB, Huddinge, 
Sweden). The inducers were diluted in RPMI 1640 medium (BioWhittaker, Cambrex 
Bioscience, Verviers, Belgium) supplemented as described below but without fetal 
calf serum. The inducers were used at a final concentration of AbISCO®-100 (1 
µg/ml), LPS (10 µg/ml) or ODN 2216 (5 µg/ml) in the cultures. 
 
Isolation of peripheral blood mononuclear cells (PBMC) 
Blood samples were collected in heparinized, 10-ml evacuated test tubes (BD 
Vacutainer System, Plymouth, UK) from five pigs conventionally reared at the 
University Research Station, Funbo Lövsta, Uppsala, Sweden. PBMC were separated 
from plasma, neutrophils and erythrocytes by density gradient centrifugation on 
Ficoll-pague (Amersham Pharmacia Biotech, Uppsala, Sweden) for 45 minutes at 
1800 rpm (without brake). The band containing PBMC was collected and transferred 
to new test tubes. Phosphate buffered saline (PBS) was added to the PBMC and the 
PBMC were washed three times by centrifugation for 10 minutes at 1000 rpm (with 
brake). A final wash in PBS to remove any thrombocytes was performed by 
centrifugation for 5 min at 1500 rpm. Cells were resuspended in complete medium 
(RPMI 1640 supplemented with 20 mM HEPES buffer, 2 mM L-glutamine, 200 IU 
penicillin/ml, 100 µg/ml streptomycin 0.5 µM 2-mercaptoethanol and 5% fetal calf 
serum (Invitrogen, Life Technologies, Carlsbad, CA, USA). Ten µl was used to 
determine the total amount of PBMC by counting in Türks solution that lyses red 
blood cells and thereby facilitates the estimation of the number of the PBMC. The 
concentration of PBMC was adjusted to 10 x 106 cells per ml culture medium.  
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Cell cultures for analysis of cytokine, CXCR4 and RGS16 mRNA expression were 
established in 25 cm2 tissue culture flasks (Nunc, Roskilde, Denmark) at a volume of 
1.5 ml/flask. Then an equal volume of the inducers: AbISCO®-100, LPS, ODN 2216 
or plain medium was added to a final volume of 3 ml/flask.  
The cell cultures were incubated for 6 hours at 37°C, 7% CO2 and thereafter 
transferred to 10 ml tubes and centrifuged for 5 min at 1500 rpm. A part of the 
supernatants (1 ml) was collected and stored at -20°C for conceivable further analysis. 
 
In parallel, cell cultures for proliferation and viability tests were established in round 
bottomed 96-well microtiter plates (Nunc, Roskilde, Denmark) at a concentration of 2 
x 105 cells per well (100 µl/well). AbISCO®-100, LPS, ODN 2216 or medium was 
added to a final volume of 200 µl/well. 
 
The final concentration of the cells in the tissue culture flasks was 5 x 106 cells per ml. 
Final concentration of the cells in the wells in the microtiter plate was 1 x 106cells per 
ml.  
 
Extraction of RNA and cDNA synthesis 
Total RNA was isolated by combining the recommended protocols for Trizol 
Reagent (Invitrogen, Life Technologies, Carlsbad, CA, USA) and E.Z.N.A.  total 
RNA Kit I (Omega Bio-tek, Norcross, GA). In brief, the cell pellets (containing 
approximately 15 x 106 cells) were resuspended in Trizol (2 ml/flask), mixed and 
incubated for 5 minutes. The samples were aliquoted to two eppendorf tubes (1 
ml/tube) and stored at -80°C. The concentration and purity of the RNA was measured 
(OD ratio 260/280) by spectrophotometry (NanoDrop ND-1000, NanoDrop 
Technologies, Montchamin, DE.). The isolated RNA was treated with Dnase (Rnase-
free Dnase Kit, Promega, Madison, WI)  accordning to manufactures instructions, but 
with an extended incubation time of 40 minutes to eliminate any residual DNA in the 
samples. The synthesis of complementary DNA (cDNA) was performed according to 
Superscript II Reverse Transcriptase kit protocol (Invitrogen, Carlsbad, CA). The first 
cDNA strand was synthesized using 2 µg of RNA as template.  In addition to the 
regular cDNA synthesis, a mixture without Superscript II reverse transcriptase was 
made and run in parallel to those with the enzyme added. This was used as a control 
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enabling the detection of genomic DNA as the gene encoding IFN-α lacks introns. 
The cDNAs were stored at -20°C. 
 
Proliferation and viability tests of PBMC 
Proliferation and viability tests were performed on PBMC obtained from three of the 
pigs. The proliferation of the PBMC was tested after 48 hours of incubation with the 
various stimulators. Cells stimulated with AbISCO®-100, LPS, ODN 2216 or plain 
medium were cultured in 96-well micro titer plates in triplicates for 24 hours at 37°C, 
7% CO2. Thereafter 25 µl of 3H-thymidine (0.5µCi 3H-thymidine specific activity 5 
Ci/mmol; Amersham, England) was added to two wells in each triplicate. After 24 
hours in the presence of 3H-thymidine (total incubation time with the stimulators, 48 
hours), the cells were harvested onto nitrocellulose filters and the amount of 
incorporated 3H-thymidine (radioactivity, counts per minute) was measured in a liquid 
scintillation β-counter (Betaplate; LKB Wallac, Turku, Finland). The relative 
proliferation expressed as stimulation index (SI) was calculated by dividing the cpm 
values of the stimulated cultures with cpm values of unstimulated cultures. 
 
The viability test was performed on cells in one well from each triplicate, after 24 
hours of incubation. The cell cultures were stained with Trypan Blue to distinguish 
viable from non-viable cells. The proportion of dead cells was determined by counting 
in a Bright-line hematocytometer metalized counting chamber (Becton Dickinson).  
 
Quantification of cytokine, CXCR4 and RGS16 mRNA expression in PBMC  
The level of cytokine, CXCR4 and RGS16 mRNA expression in porcine PBMC was 
measured after various stimulations (AbISCO®-100, LPS, ODN 2216 or medium) 
using Quantitative Taqman real-time PCR (qRT-PCR). The qRT-PCR was performed 
for IFN-α, IFN-γ, IL-6, IL-10, IL-12p40, IL-1β, TNF-α, TGF-β, CXCR4, RGS16 
 and two reference genes, Cyclophilin A (CyA) and Hypoxanthine-guanine 
phosphoribosyl transferase (HPRT), using previously published primers and probes 
(Table 1). As a control the IFN-α analysis was also run on cDNA prepared in the 
absence of reverse transcriptase. The cDNA was diluted 5 times in sterile water and 
added in 1.1 µl volumes in triplicate 25 µl reactions, containing 1x ABsoluteTM QPCR 
Mix (ABgene, Epsome, UK), 0.4 µM forward primer, 0.4 µM reverse primer and 0.2 
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µM 5´-6-carboxyfluorescein (FAM) and 3´-Black Hole Quencer 1 (BHQ1) labeled 
probe. The samples were amplified and analyzed in an IQ5 Real Time PCR machine 
(Biorad, Hercules, CA) using an initial 15 min at 95°C followed by 40 cycles of 15 s 
at 95°C and 60°C for 30 s. The FAM fluorescence signal was measured at the 60°C 
step for each cycle.  
Relative mRNA expression levels of cytokines, CXCR4 and RGS16 in comparison to 
the reference genes in the different samples were calculated by using the following 
formula:  
 
 
 
Where x and y is equal to the following formulas: 
x = CtStimulation,Target/ ((CtStimulation,Ref1+CtStimulation,Ref2)/2) 
 
y = CtMedium, Target / ((CtMedium,Ref1+CtMedium,Ref2)/2) 
 
The formula used for calculation of the relative mRNA expression (R) is composed by x and y and then 
inverted. 
 
In brief, the relative mRNA expression of the target genes (eight selected cytokines, 
CXCR4 and RGS16) in comparison to the reference genes (Cy A = Ref1 and HPRT = 
Ref2) was estimated by comparing the Ct mean values (mean values of triplicates). 
First the target gene expression was divided with the mean value of expression of the 
two reference genes of the stimulated PBMC. This value was then related to the target 
gene expression of PBMC cultured in plain growth medium divided with the 
expression of the two reference genes in PBMC cultured in plain growth medium. The 
results were inverted in relation to each other, by taking 1 divided with the result.  
 
Statistical analysis  
To analyze whether the different treatments (AbISCO®-100, LPS and ODN 2216, 
respectively) differed in their cytokine inducing capacity the paired t-test (Student’s t-
test) was used. The t-test was performed by comparing the values generated from the 
formula for calculation of the relative mRNA expression, which is given above. P 
values less than 0.05 were considered statistically significant. 
 
Ct   = Ct mean value of triplicate 
Stimulation  = AbISCO®-100, LPS or ODN 2216 
Target   = 8 various cytokines, CXCR4 or RGS16 
Ref1 and Ref2 = CyA and HPRT 
Medium   = Treatment of PBMC with plain medium 
R  = Relative mRNA expression 
R = 1÷ (x/y) 
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Results 
 
Proliferation analyses and viability test of PBMC 
The viability test of PBMC from three of the pigs, showed up to 20% of dead cells 
after 24 hours of incubation in the presence of 1 µg AbISCO®-100 per ml. The 
viability of the cells incubated for 24 hours with ODN 2216 or LPS were similar or 
occasionally lower than for cells cultured in plain medium. The death of non-treated 
cells (cultured in plain growth medium) was approximately 6 % (Table 2).  
 
The proliferative capacity of PBMC obtained from three of the pigs was tested on 
cells which had been stimulated with AbISCO®-100, LPS, ODN 2216 or cultured in 
plain growth medium for 48 h (Figure 1). The spontaneous proliferation (cells 
cultured in plain growth medium) was approximately two times higher for PBMC 
isolated from pig no. 4 than for PBMC isolated from pig no. 3 and no. 5. For all three 
pigs, PBMC stimulated with ODN 2216 showed the highest proliferation, samples 
stimulated with LPS had a moderate proliferation whereas the samples stimulated 
with AbISCO®-100 had the lowest proliferation. 
 
Expression of mRNA for selected cytokines, CXCR4 or RGS16 after 6 h of 
stimulation with the inducers 
In the first series of experiments, where the mRNA expressions from pig no. 1 and no. 
2 were examined, the mRNA expressions were related to each reference gene 
separately as well as to the mean value of the two reference genes. No difference in 
the mRNA expression levels of the examined genes was observed after they had been 
related to each reference gene separately or to a mean value of both reference genes. 
Therefore following calculations were performed using only the mean value of 
mRNA expression of the two reference genes. In general, the results obtained from 
the five pigs were in good agreement as illustrated by the small SD values (Figure 2). 
The compiled results are given in Table 3. 
 
The result of PBMC from the five pigs stimulated with AbISCO®-100 showed no 
significant increase in mRNA expression of the different target genes examined 
except for TNF-α (Table 3). The increase in TNF-α mRNA expression was low and 
had a p value ≤ 0.05. In PBMC from one of the pigs (pig no. 1) a small increase in the 
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relative mRNA expression of IL-10 (R=1.0365), CXCR4 (R=1.0432) and RGS16 
(R=1.0808) was seen after stimulation with AbISCO®-100.  
 
The porcine PBMC stimulated with LPS showed significant increases in mRNA 
expressions with the highest levels of expression of IL-1β,  IL-6, IL-10 (p ≤ 0.001) 
and lower levels of expression of TNF-α and IL-12p40  (p ≤ 0.01). Low but 
significant decreases in mRNA expression after stimulation with LPS was detected for 
IFN-α and TGF-β (p ≤ 0.05). 
 
The porcine PBMC stimulated with ODN 2216 showed a significant increase in 
mRNA expression with high levels of expression for IFN-α (p ≤ 0.01) and IL-12p40 
(p ≤ 0.05) and lower levels of IL-6, TNF-α, IFN-γ and IL-10 (p ≤ 0.05). A low but 
significant decrease in mRNA expression after stimulation with ODN 2216 was 
detected for CXCR4 (p ≤ 0.01). 
 
The LPS-induced expression of IL-1β, IL-6, IL-10, IL-12p40 and TNF-α in porcine 
PBMC was expected as well as the IFN-α, IL-12p40, IL-6 and IFN-γ induction by 
ODN 2216. Taken together these positive controls prove that the methodology used is 
applicable and that the present qRT-PCR is useful for detection of these target genes. 
The methods used thus appear to be appropriate for examination of responses elicited 
after stimulation of porcine PBMC with AbISCO®-100. 
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Discussion 
 
In vitro exposure of porcine PBMC to AbISCO®-100 for 6 hours had no profound 
effect on the mRNA expression of a number of cytokine genes. Of the eight cytokines 
analyzed, only a slight increase in the expression of mRNA for TNF-α was detected 
and neither the expression of the chemokine receptor CXCR4 or its regulator RGS16 
was altered. These results are in agreement with the absence of fever and local 
reactions in toxicity tests performed by injection of seven days old piglets with 
varying doses (up to 150 µg) of iscom matrix (McIntosh et al., manuscript).  
 
To study effects of AbISCO®-100 on the viability of porcine PBMC the cells were 
incubated in the presence of AbISCO®-100 for 24 hours. Parallel incubations were 
established with LPS and ODN 2216. The higher proportion of dead cells among 
PBMC cultured in presence of AbISCO®-100 compared to the other inducers 
indicates that in vitro exposure of porcine PBMC to AbISCO®-100 (1 µg/ml, 24 
hours) affects their viability. The fraction-C saponin that is present in combination 
with the fraction-A saponin in the formulation AbISCO®-100 has a strong lytic effect 
on PBMC itself. If AbISCO®-100 has been taken up by the cells and then been 
degraded, the content of Fraction-C saponin could theoretically exert a lytic effect.  
 
The proliferation test performed showed that non-stimulated PBMC (grown in plain 
medium) had a low spontaneous proliferation. The spontaneous proliferation was 
slightly higher for PBMC isolated from pig no. 4 than from the other two pigs tested 
which could reflect an in vivo activation prior to the collection of blood samples. 
Regardless of the initial status, the proliferative response of the PBMC was 
consistently lower after stimulation with AbISCO®-100 than after stimulation with 
LPS or ODN 2216, indicating that AbISCO®-100 is not mitogenic for porcine 
PBMC. However the cell division, determined by incorporation of 3H thymidine 
during the last 24 of the 48 hours of culture, confirmed that a considerable proportion 
of the PBMC were still alive and dividing despite the slight decrease in viability 
observed after 24 hours. 
 
A small increase in expression of TNF-α was observed for PBMC stimulated with 
AbISCO®-100 from four of the five pigs. This indicates that AbISCO®-100 may 
have the property to induce an inflammatory response. Indeed, analyses of mRNA 
collected from two of the pigs after 20 hours of incubation showed an increased 
expression of mRNA for IL-1β at that time (results not shown). After 6 hours of 
incubation with AbISCO®-100 a small increase in the expression of IL-10, CXCR4 
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and RGS16 was found in PBMC from one of the pigs when compared to non-
stimulated PBMC. A previous study by Morein et al. (2004) has shown that one 
specific feature of iscom matrix is the capacity to simultaneously induce both a Th1 
and Th2 type of immune response. The production of IL-10 is usually up regulated 
during a Th2 response. The results from the PBMC from pig no. 1 therefore indicate 
that AbISCO®-100 at certain conditions can induce cytokines associated with a Th2 
type of response in the pig.  
 
Monocytes and naïve B and T lymphocytes normally express the chemokine receptor 
CXCR4, which facilitate the migration of the cells to lymphoid organs. CXCR4 is a G 
protein coupled receptor, which can be down modulated by binding to its ligand, 
stromal-derived factor-1 (SDF-1) (Cole SW et al. 1999 and Signoret N et al.1997). 
The increased expression of CXCR4 is probably just a normal feature in the migration 
of naive lymphocytes to the lymphoid organs. An up-regulation of RGS16, as 
indicated in pig no. 1, could aim to counteract the increased expression of CXCR4. 
Such an inhibition of CXCR4 due to an increased expression of RGS16 appears 
logical as RGS16 down-regulates CXCR4 in megakaryocytes (Berthebaud et al., 
2005). However this result was only observed in one of the five pigs, which 
emphasizes the need to perform the tests on PBMC collected from a larger number of 
pigs and to include additional cytokines representing a Th2 type of response. 
 
Stimulation of the PBMC with LPS for 6 hours was included as a positive control for 
induction of mRNA expression for IL-1β, IL-12p40, IL-10 and TNF-α since an 
increase of these cytokines is known to accompany the early response to LPS (Boeuf 
et al., 2005). An increased expression of the pro-inflammatory cytokines IL-1β, IL-12 
and TNF-α was expected since they are released by activated macrophages and 
dendritic cells during the early stage of an immune response e.g. against a bacterial 
infection. Also an increase in the expression of IL-6 was expected since this cytokine 
is generally produced in response to LPS stimulation. Macrophages and endothelial 
cells stimulated by IL-1 and TNF-α, elicits IL-6, which promotes the differentiation 
of T and B cells and stimulates an acute-phase response. In accordance, the expression 
of mRNA for IL-1β,  IL-6, IL-10 and TNF-α was increased in porcine cells collected 
from the mammary gland 24 h after inoculation with Escherichia coli. This expression 
 
 
 14 
of genes for pro-inflammatory cytokines was correlated with fever and other clinical 
symptoms of mastitis (Zhu et al. 2008). Thus, LPS seemed to be a proper control for 
induction of a cytokine profile associated with the later development of a Th2 type of 
immune response.  
 
Indeed, an increased expression of mRNA for IL-1β, IL-12p40, IL-10 and TNF-α was 
detected in the present study for PBMC stimulated with LPS. In addition, a slight 
decrease in expression (lower level of expression than in medium) was found for IFN-
α and TGF-β. The decrease in expression of IFN-α after stimulation with LPS may be 
due to that this cytokine is needed mainly against intracellular infectious agents (e.g. 
viruses) and is not essential during an extracellular bacterial infection. Thus it is more 
efficient for the immune system to favour the important pro-inflammatory cytokines 
released during an early immune response towards a bacterial infection, for example 
via LPS. The decrease in expression of TGF-β could be explained by its 
immunosuppressive properties; it is usually secreted in the late stages of an immune 
response to inhibit proliferation of both T and B lymphocytes. TGF-β also activates 
macrophages in order to suppress the immune activities when its no longer needed.  
 
Stimulation of the PBMC with ODN 2216 for 6 hours was used as a positive control 
for the expression of IFN-α, IL-12p40, IL-6 and IFN-γ because expression of these 
cytokine genes has been observed after in vitro exposure of porcine PBMC to this 
CpG ODN (Andersson et al. 2007). The cytokine IL-12 has a central role for 
activation of various cell types in the immune system and also for further cytokine 
secretions. For example, IL-12 has the capability to activate macrophages and natural 
killer cells and stimulate the secretion of IL-6 and IFN-γ. The antiviral cytokine IFN-
α is produced during early stages of a viral infection and is usually induced by 
intracellular signalling from endosomal TLR9 (Jiang et al. 2005). Therefore, ODN 
2216 that activates cytokine production via TLR9 was used to mimic a virus-induced 
cytokine response that subsequently commonly leads to a Th1 type of immune 
response.  In the present study the mRNA expressions of IFN-α, IL-12p40, IL-6 
and IFN-γ of the PBMC induced by ODN 2216 also agreed well with the predicted 
response. In addition, increased expression of mRNA for IL-10 and TNF-α were 
observed. In general, IL-12 induces differentiation of Th1 cells resulting in a Th1 
immune response i.e. production of IL-2 and IFN-γ. Th2 cells normally produce IL-10 
to inhibit a Th1 response to maintain the homeostatic state of innate and cell-mediated 
 
 
 15 
immune reactions. A low increase in expression of IL-10 may therefore be due to Th2 
cells secreting IL-10 to inhibit the elicited Th1 type of response. The decrease in the 
expression of CXCR4 due to the stimulation with ODN 2216 can be explained by that 
the chemokine receptor is usually down-regulated during cellular activation (Signoret 
et al.1997).  
 
Because of the short period of incubation the majority of cytokines induced by the in 
vitro stimulators are most likely to be produced by cells of the innate immunity such 
as dendritic cells and monocyte/macrophages. In the present study however the 
PBMC were obtained from conventionally reared pigs that are likely to be “primed” 
by previous exposure to a number of microorganisms. Thus, the detection of mRNA 
for some T-cell derived cytokines that are elicited by the in vitro “re-stimulation” can 
be expected. From a practical point of view this is the likely situation when 
vaccinating animals and therefore the modest detection of T-cell cytokines observed 
during the present conditions are promising.  
 
In the present study quantitative real-time PCR was used to determine the mRNA 
expression of cytokines, CXCR4 and RGS16. Quantitative real-time PCR is a rapid, 
and sensitive technique commonly used for detection of the mRNA expression levels 
in different cells and tissues (Giulietti et al. 2001). The relative mRNA expression of 
the various cytokines, CXCR4 and RGS16 was used to evaluate the expression of the 
genes. The relative expression was calculated by comparing the mRNA expression of 
one gene to a mean value of expression of two reference genes. The reference genes 
should be constantly expressed in the samples regardless of treatment. There where 
two reference genes used in this experiment: one with a high expression level, 
cyclophilin A and one with a lower expression level, HPRT. The relative expression 
of the cytokines, CXCR4 and RGS16, after various stimulation were also compared to 
the mRNA expression level in samples treated with plain growth medium. The level 
of mRNA expression of some cytokines was below the detection limit (40 cycles) for 
the qRT-PCR assay. Expression levels below this limit was therefore given a Ct value 
of 40 cycles in the mathematical calculations. Furthermore, the present study was 
conducted on samples from only five pigs. Such a population is quite restricted and 
may not give representative results and to get a more reliable result the amount of 
animals tested should be expanded. Another suggestion for further studies is to use a 
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well-known method for estimation of the relative mRNA expression e.g. using the 
geometric mean method according to Vandesompele et al. (2002), thereby enable 
comparison to previously published results. Nevertheless, the immune stimulating 
complex matrix, AbISCO®-100, does not seem to elicit any massive and uncontrolled 
immune activation by itself and it does not have a strong lytic effect on porcine 
PBMC. It may have a small immune stimulating capacity by itself but not notably 
high at this concentration and time of stimulation. Thus, further studies are needed 
with PBMC obtained from a greater number of pigs and using a wider range of matrix 
concentrations and periods of incubation. The measurements should also be expanded 
to include more cytokines/chemokines and their receptors.  
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Table 1. Primers and probes used for detection of mRNA expression by Quantitative Taqman real-time 
PCR 
 
Gene  
  
Oligonucleotide sequences (5’-3’) 
 
IFN-α1   FW    AGC CTC CTG CAC CAG TTC TG 
 RV    TCA CAG CCA GGA TGG AGT CC 
 Pr      5AG GCT TCC AGG TCC CTG AGC TGC TX 
 
IFN-γ1   FW    TGG TAG CTC TGG GAA ACT GAA TG 
 RV     GGC TTT GCG CTG GAT CTG 
 Pr       5CT TCG AAA AGC TGA TTA AAA TTC CGG TAG ATA ATC TGC X 
 
IL-61   FW    CTG GCA GAA AAC AAC CTG AAC C 
 RV     TGA TTC TCA TCA AGC AGG TCT CC 
 Pr       5TT GAA CCC AGA TTG GAA GCA TCC GTC TTT TX  
 
IL-101   FW    CGG CGC TGT CAT CAA TTT CTG 
 RV     CCC CTC TCT TGG AGC TTG CTA 
 Pr       5AG GCA CTC TTC ACC TCC TCC ACG GCX 
 
IL-1β1   FW    GTG ATG GCT AAC TAC GGT GAC AA 
 RV     CTC CCA TTT CTC AGA GAA CCA AG 
 Pr       5AA TAA TGA CCT GTT ATT TGA GGC TGA TGG CX 
 
TNF-α1   FW    AGC CTC TTC TCC TTC CTC CTG 
 RV     GAG ACG ATG ATC TGA GTC CTT GG 
 Pr       5AG GAG CCA CCA CGC TCT TCT GCC TX 
 
TGF-β1   FW    TAC GCC AAG GAG GTC ACC C 
 RV     CAG CTC TGC CCG AGA GAG C 
 Pr        5CT AAT GGT GGA AAG C G GC AAC CAA ATC TAX 
 
IL-12p401   FW     TCT TGG GAG GGT CTG GGT TG 
 RV     AAG CTG TTC ACA AGC TCA AGT ATG A 
 Pr       5AC CAG CAG CTT CTT CAT CAG GGA CAT CAX 
 
HPRT1 
 
  FW    GTG ATA GAT CCA TTC CTA TGA CTG TAG A 
 RV     TGA GAG ATC ATC TCC ACC AAT TAC TT 
 Pr        5AT CGC CCG TTG ACT GGT CAT TAC AGT AGC TX 
 
CyA1   FW    TGC TTT CAC AGA ATA ATT CCA GGA TTT A 
 RV     GAC TTG CCA CCA GTG CCA ATT A 
 Pr       5TG CCA GGG TGG TGA CTT CAC ACG CCX 
 
CXCR42  FW     CAT CTT CTT AAC TGG CAT AGT GGG TAA 
 RV     CCG TCA TGC TTC TCA GTT TCT TC 
 Pr       5CT GGT AAC CCA TGA CCA GGA TGA CCA ATC X 
 
RGS162  FW     TCC GAT CCC GCG AGT GT 
 RV     CAC TCC ATT TTT ACT GCT CAG CAA 
 Pr       5CT TTG CTG TGT TTA CTG CCC CAC TCG AX 
 
1From Hasslung Wikström, F. 2008, 2 Timmusk et al. manuscript 
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Table 2. Viability of PBMC from three of the pigs, cultured in the presence of AbISCO®-100 (1 
µg/ml), LPS (10 µg/ml), ODN 2216 (5 µg/ml) or medium for 24 h 
   
Proportion (%) dead cells 
 
Inducer Pig no. 3 Pig no. 4 Pig no. 5 
AbISCO®-100 20.3 % 7.1 % 11.1 % 
LPS 8.6 % 3.6 % 8.7 % 
ODN 2216 6 % 5.1 % 2 % 
Medium 6 % 6.6 % 5.3 % 
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Table 3. Significance of increase/decrease in relative mRNA expression (R) after different treatments 
of porcine PBMC compared to cultured in plain growth medium calculated as described in material and 
method. NS = Not significant, *p≤0.05,  ** p≤0.01, *** p≤0.001; Student’s paired t-test, (n=5). 
 
Target gene 
 
AbISCO®-100 vs. medium 
p value 
 
LPS vs. medium 
p value 
 
ODN 2216 vs. medium 
p value 
IFN-α NS * ** 
IFN-γ NS NS * 
IL-6 NS *** * 
IL-10 NS *** * 
IL-1β NS *** NS 
TNF-α * ** * 
TGF-β NS * NS 
IL-12p40 NS ** * 
CXCR4 NS NS ** 
RGS16 NS NS NS 
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Figure 1. The proliferative capacity of PBMC obtained from three experimental pigs after stimulation 
with AbISCO®-100 (1 µg/ml), LPS (10 µg/ml), ODN 2216 (5 µg/ml) or plain medium for 48 h. The 
bars show proliferation after different stimulations compared to the spontaneous proliferation 
(proliferation in medium). Striped bars represent stimulation with AbISCO®-100, white bars LPS and 
grey bars ODN 2216. 
0
10
20
30
40
50
60
70
80
Pig 3 Pig 4 Pig 5
P
ro
li
fe
ra
ti
o
n
 (
S
I)
ABISCO100
LPS
2216
Cpm-värde 
Medium:
Pig 3: 246
Pig 4: 836
Pig 5: 293
 
 
 23 
  
IFN-α
0,00
0,20
0,40
0,60
0,80
1,00
1,20
1,40
1,60
Mean value of mRNA expression of five pigs
C
y
to
k
in
e
 m
R
N
A
 e
x
p
re
s
s
io
n
 
(
1
/
ra
ti
o
)
ABISCO
LPS
2216
Medium
Medium
(Ct medel):
Pig1: 36.24
Pig2: 30,76
Pig3: 33,14
Pig4: 33,83
Pig5: 33,02
IL-1β
0,00
0,20
0,40
0,60
0,80
1,00
1,20
1,40
1,60
Mean value of mRNA expression of five pigs
C
y
to
k
in
e
 m
R
N
A
 e
x
p
re
s
s
io
n
 
(
1
/
ra
ti
o
)
ABISCO
LPS
2216
Medium
Medium
(Ct medel):
Pig1: 29,76
Pig2: 30,27
Pig3: 31,96
Pig4: 30,38
Pig5: 31,75
 
 
 
TNF-α
0,00
0,20
0,40
0,60
0,80
1,00
1,20
1,40
1,60
Mean value of mRNA expression of five pigs
C
y
to
k
in
e
 m
R
N
A
 e
x
p
re
s
s
io
n
 
(
1
/
ra
ti
o
)
ABISCO
LPS
2216
Medium
Medium
(Ct medel):
Pig1: 34,72
Pig2: 34,91
Pig3: 37,94
Pig4: 36,66
Pig5: 37,04
IL-12
0,00
0,20
0,40
0,60
0,80
1,00
1,20
1,40
1,60
Mean value of mRNA expression of five pigs
C
y
to
k
in
e
 m
R
N
A
 e
x
p
re
s
s
io
n
 
(
1
/
ra
ti
o
)
ABISCO
LPS
2216
Medium
Medium
(Ct medel):
Pig1: 37,36
Pig2: 36,45
Pig3: 40,00
Pig4: 40,00
Pig5: 40,00
 
 
 
IL-6
0,00
0,20
0,40
0,60
0,80
1,00
1,20
1,40
1,60
Mean value of mRNA expression of five pigs
C
y
to
k
in
e
 m
R
N
A
 e
x
p
re
s
s
io
n
 
(
1
/
ra
ti
o
)
ABISCO
LPS
2216
Medium
Medium
(Ct medel):
Pig1: 35,18
Pig2: 35,01
Pig3: 35,76
Pig4: 34,57
Pig5: 37,11
IFN-γ
0,00
0,20
0,40
0,60
0,80
1,00
1,20
1,40
1,60
Mean value of mRNA expression of five pigs
C
y
to
k
in
e
 m
R
N
A
 e
x
p
re
s
s
io
n
 
(
1
/
ra
ti
o
)
ABISCO
LPS
2216
Medium
Medium
(Ct medel):
Pig1: 33,08
Pig2: 32,37
Pig3: 35,57
Pig4: 34,81
Pig5: 35,96
 
 
 
TGF-β 
0,00
0,20
0,40
0,60
0,80
1,00
1,20
1,40
1,60
Mean value of mRNA expression of five pigs
C
y
to
k
in
e
 m
R
N
A
 e
x
p
re
s
s
io
n
 
(
1
/
ra
ti
o
)
ABISCO
LPS
2216
Medium
Medium
(Ct medel):
Pig1: 33,95
Pig2: 31,58
Pig3: 33,70
Pig4: 33,28
Pig5: 34,44
IL-10
0,00
0,20
0,40
0,60
0,80
1,00
1,20
1,40
1,60
Mean value of mRNA expression of five pigs
C
y
to
k
in
e
 m
R
N
A
 e
x
p
re
s
s
io
n
 
(
1
/
ra
ti
o
)
ABISCO
LPS
2216
Medium
Medium
(Ct medel):
Pig1: 32,36
Pig2: 31,37
Pig3: 33,56
Pig4: 31,67
Pig5: 32,46
 
 
 
 
 
 24 
CXCR4
0,00
0,20
0,40
0,60
0,80
1,00
1,20
1,40
1,60
Mean value of mRNA expression of five pigs
C
y
to
k
in
e
 m
R
N
A
 e
x
p
re
s
s
io
n
 
(
1
/
ra
ti
o
)
ABISCO
LPS
2216
Medium
Medium
(Ct medel):
Pig1: 27,45
Pig2: 26,41
Pig3: 29,58
Pig4: 28,81
Pig5: 29,77
RGS16
0,00
0,20
0,40
0,60
0,80
1,00
1,20
1,40
1,60
Mean value of mRNA expression of five pigs
C
y
to
k
in
e
 m
R
N
A
 e
x
p
re
s
s
io
n
 
(
1
/
ra
ti
o
)
ABISCO
LPS
2216
Medium
Medium
(Ct medel):
Pig1: 35,61
Pig2: 36,05
Pig3: 37,29
Pig4: 36,57
Pig5: 37,29
 
 
Figure 2. Total RNA was extracted, cDNA synthesized and quantified by qRT-PCR to determine 
cytokine, CXCR4 and RGS16 mRNA expression levels as described in material and methods. The bar 
graphs displays the mRNA expressions of IFN-α, IFN-γ, IL-6, IL-10, IL-12p40, IL-1β, TNF-α, TGF-β, 
CXCR4, RGS16 normalized to two reference genes (cyclophilin A and HPRT) and the mean±SD 
within the five pigs.  
